Publications
Response to the structural transformation of the pharma industry [German only]
Bert Klebl, Peter Nussbaumer and Matthias Stein-Gerlach; transkript | Special Issue Kapital & Börse May 2009
>> download PDF >>Transkript Online
PBMC-backed Identification of Lead Structures [German Only]
Peter Habenberger, Axel Choidas, Bert Klebl, Jan Eickhoff
LaborWelt Nr. 4/2009 - 10th Volume
Pages 4 - 6
Small-molecule inhibitors binding to protein kinases.
Part I: exceptions from the traditional
AC Backes, B Zech, B Felber, B Klebl, G Muller -
Expert Opin. Drug Discov., 2008
>>www.informapharmascience.com
Small-molecule inhibitors binding to protein kinase.
Part II: the novel pharmacophore approach of type II
and type III inhibition
AC Backes, B Zech, B Felber, B Klebl, G Muller -
Expert Opin. Drug Discov., 2008
>>www.informapharmascience.com
Data handling and processing in proteomics
Hamacher M, Stephan C, Meyer HE, Eisenacher M. -
Expert Rev Proteomics. 2009 Jun;6(3):217-9
>> download PDF >>Expert Rev Proteomics
Polishing Medical Rough Diamonds
Text: Marcus Anhäuser
Max Planck Society Magazine Special "Innovation" / 2009
Pages 47 - 53
>> download PDF >>Max Planck multimedia
From Fragment Screening to Potent Binders: Strategies for Fragment-to-Lead Evolution.
Eitner K, Koch U. -
Mini Rev Med Chem. 2009 Jul;9(8):956-61.
